Causeway Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $52.7M | Sell |
578,238
-227,271
| -28% | -$20.7M | 0.83% | 24 |
|
2025
Q1 | $91.2M | Buy |
805,509
+35,577
| +5% | +$4.03M | 1.91% | 9 |
|
2024
Q4 | $81.3M | Sell |
769,932
-24,356
| -3% | -$2.57M | 1.85% | 9 |
|
2024
Q3 | $85.7M | Buy |
794,288
+133,482
| +20% | +$14.4M | 2.11% | 11 |
|
2024
Q2 | $71.7M | Buy |
660,806
+154,551
| +31% | +$16.8M | 1.96% | 12 |
|
2024
Q1 | $66.8M | Sell |
506,255
-58,414
| -10% | -$7.71M | 1.75% | 14 |
|
2023
Q4 | $68.7M | Buy |
564,669
+158,806
| +39% | +$19.3M | 1.75% | 16 |
|
2023
Q3 | $45.5M | Buy |
405,863
+179,845
| +80% | +$20.2M | 1.2% | 24 |
|
2023
Q2 | $32.9M | Sell |
226,018
-197,872
| -47% | -$28.8M | 0.87% | 33 |
|
2023
Q1 | $54.8M | Sell |
423,890
-8,072
| -2% | -$1.04M | 1.31% | 19 |
|
2022
Q4 | $55.1M | Sell |
431,962
-27,247
| -6% | -$3.47M | 1.6% | 16 |
|
2022
Q3 | $48M | Sell |
459,209
-62,564
| -12% | -$6.54M | 1.35% | 21 |
|
2022
Q2 | $54.8M | Sell |
521,773
-34,425
| -6% | -$3.62M | 1.37% | 21 |
|
2022
Q1 | $71.1M | Buy |
556,198
+307,079
| +123% | +$39.3M | 1.7% | 23 |
|
2021
Q4 | $30.7M | Buy |
+249,119
| New | +$30.7M | 0.68% | 41 |
|
2019
Q4 | – | Sell |
-1,039,700
| Closed | -$139M | – | 95 |
|
2019
Q3 | $139M | Sell |
1,039,700
-99,135
| -9% | -$13.2M | 1.66% | 21 |
|
2019
Q2 | $130M | Buy |
1,138,835
+58,702
| +5% | +$6.71M | 1.42% | 24 |
|
2019
Q1 | $134M | Sell |
1,080,133
-274,794
| -20% | -$34.1M | 1.35% | 22 |
|
2018
Q4 | $136M | Buy |
1,354,927
+106,091
| +8% | +$10.7M | 1.63% | 22 |
|
2018
Q3 | $159M | Buy |
1,248,836
+25,337
| +2% | +$3.23M | 1.6% | 22 |
|
2018
Q2 | $132M | Buy |
+1,223,499
| New | +$132M | 1.34% | 24 |
|